These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27788803)

  • 21. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
    Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
    Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
    Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
    Arthurs SK; Eid AJ; Pedersen RA; Kremers WK; Cosio FG; Patel R; Razonable RR
    Clin Infect Dis; 2008 Mar; 46(6):840-6. PubMed ID: 18260785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
    Chiasakul T; Townamchai N; Jutivorakool K; Chancharoenthana W; Thongprayoon C; Watanatorn S; Avihingsanon Y; Praditpornsilpa K; Srisawat N
    Transplant Proc; 2015 Oct; 47(8):2460-4. PubMed ID: 26518951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients.
    Díaz J; Henao J; Rodelo J; García A; Arbeláez M; Jaimes F
    Transplant Proc; 2014; 46(1):160-6. PubMed ID: 24507044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH; Mao YY; He Q; Wu JY; Lv R
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of high anti-CMV IgG titer with renal function decline and allograft rejection in kidney transplant patients.
    Chen TH; Ou SM; Tarng DC
    J Chin Med Assoc; 2022 Feb; 85(2):183-189. PubMed ID: 34882099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
    Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
    Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxis.
    Felipe CR; Ferreira AN; Bessa A; Abait T; Ruppel P; Paula MI; Hiramoto L; Viana L; Martins S; Cristelli M; Aguiar W; Mansur J; Basso G; Silva Junior HT; Pestana JM
    J Bras Nefrol; 2017; 39(4):413-423. PubMed ID: 29319768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.
    Reischig T; Kacer M; Hruba P; Jindra P; Hes O; Lysak D; Bouda M; Viklicky O
    Antivir Ther; 2017; 22(6):503-513. PubMed ID: 28091392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.
    Leone F; Gigliotti P; Mauro MV; Lofaro D; Greco F; Tenuta R; Perugini D; Papalia T; Mollica A; Perri A; Vizza D; La Russa A; Toteda G; Lupinacci S; Giraldi C; Bonofiglio R
    Transpl Infect Dis; 2016 Apr; 18(2):191-201. PubMed ID: 26878346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
    Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
    Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does CMV infection increase the incidence of infective endocarditis following kidney transplantation?
    Einollahi B; Lessan-Pezeshki M; Pourfarziani V; Nemati E; Nafar M; Pour-Reza-Gholi F; Ghadyani MH; Farahani MM
    Ann Transplant; 2009; 14(1):32-7. PubMed ID: 19289994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
    Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
    Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study.
    Khameneh ZR
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):41-5. PubMed ID: 18087121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients.
    Nafar M; Roshan A; Pour-Reza-Gholi F; Samadian F; Ahmadpoor P; Samavat S; Abbasi MA
    Iran J Kidney Dis; 2014 May; 8(3):231-5. PubMed ID: 24878947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.